Thomas Wright, MD
Phlebology · O Fallon, MONPI 1417935974
Payments from drug & device makers
Across 116 payments — averaging $237.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$22K
- Microaire Surgical Instruments LLC$5K
- Apyx Medical Corporation$139
- Galderma Laboratories, L.p.$102
- Revance Therapeutics, Inc.$95
- Merz North America, Inc.$73
- plus $120 from 5 others
What the payments were for
- Consulting fees$6,25046%
- Speaking & faculty fees$5,20038%
- Food & beverage$2,24716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 91 | $21,919 |
| Microaire Surgical Instruments LLC | 6 | $5,050 |
| Apyx Medical Corporation | 1 | $139 |
| Galderma Laboratories, L.p. | 6 | $102 |
| Revance Therapeutics, Inc. | 4 | $95 |
| Merz North America, Inc. | 2 | $73 |
| Boston Scientific | 2 | $42 |
| Bsn Medical Inc | 1 | $29 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Cashflow Solutions, LLC | 1 | $14 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Flexitouch Plus$5,609
- ENTRE$4,102
- PAL$2,850
- Entre Plus$2,508
- Aesthetics - LipoFilter$2,200
- FLEXITOUCH$1,400
- ACTITOUCH$1,400
- Nimbl$400
How this compares
Too few phlebology providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $322 |
| Rifampin | 20 | $228 |
| Spironolactone-HctzSpironolact/Hydrochlorothiazid | 12 | $70 |
| Cephalexin | 15 | $57 |
| Tramadol Hcl | 14 | $43 |
| Lorazepam | 15 | $18 |
| Hydromorphone Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other phlebology in O Fallon
- Philip RumbaoaJefferson City$2K
- Michael NellesteinSaint Joseph$888
- William GoldsteinChesterfield$513
- Sameer GuptaSaint Joseph$102
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.